Enzalutamide ± Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
J. Clin. Oncol 2023 Mar 30;[EPub Ahead of Print], MJ Morris, G Heller, DW Hillman, O Bobek, C Ryan, ES Antonarakis, AH Bryce, O Hahn, H Beltran, AJ Armstrong, L Schwartz, LD Lewis, JH Beumer, B Langevin, EC McGary, PT Mehan, A Goldkorn, BJ Roth, H Xiao, C Watt, ME Taplin, S Halabi, EJ SmallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.